Clinical Trial Update: Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the pharmacokinetics and safety of Nanogam 100 mg/mL intravenous immunoglobulin has completed in patients with primary immunodeficien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Nanogam 100 mg/ml (intravenous immunoglobulin)

Snippet

Sponsor: Prothya Biosolutions | Conditions: Primary Immunodeficiency | Phase 3 | Status: COMPLETED